Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Lamin A + C Antibody (4H7), Novus Biologicals™
SDP

Rabbit Monoclonal Antibody

Supplier:  Novus Biologicals NBP32616750UL

 View more versions of this product

Catalog No. NB298642


Only null left
Add to Cart

Description

Description

Lamin A + C Monoclonal antibody specifically detects Lamin A + C in Human samples. It is validated for Flow Cytometry, ELISA, Immunohistochemistry, Immunoprecipitation, Immunocytochemistry
Specifications

Specifications

Lamin A + C
Monoclonal
Unconjugated
PBS, pH 7.4, 150mM NaCl and 50% glycerol
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Flow Cytometry, ELISA, Immunohistochemistry, Immunoprecipitation, Immunocytochemistry
4H7
Flow Cytometry, ELISA, Immunohistochemistry 1:50-1:200, Immunoprecipitation 1:200-1:1000, Immunocytochemistry/Immunofluorescence 1:20-1:200
CDCD1, CDDC, CMD1A, CMT2B1, dilated 1A (autosomal dominant), EMD2, FPLD, HGPSFPL, lamin A/C, lamin A/C-like 1, lamin-A/C, LDP1, LFP, LGMD1B, limb girdle muscular dystrophy 1B (autosomal dominant), LMN1IDC, LMNC, LMNL1, prelamin-A/C, PRO1,70 kDa lamin, progeria 1 (Hutchinson-Gilford type), renal carcinoma antigen NY-REN-32
A synthesized peptide derived from Human Lamin A + C [UniProt P02545]
50 μL
Apoptosis, Cell Biology, Cell Cycle and Replication, Cytoskeleton Markers, Protein Phosphatase, Signal Transduction, Stem Cells
4000
Store at -20 to -70C. Avoid freeze-thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.